Back

Cardiac resynchronization therapy, remodeling and outcome in patients with amyloid transthyretin cardiomyopathy

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis uncovered: from clues to cutting-edge care Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

2 More presentations in this session

Presentation thumbnail
Malnutrition, frailty, and physical performance in transthyretin cardiac amyloidosis: insights from a prospective multicenter cohort study
Doctor C. Fumagalli (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis
Professor M. Merlo (Trieste, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis uncovered: from clues to cutting-edge care
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Cardiac resynchronization therapy, remodeling and outcome in patients with amyloid transthyretin cardiomyopathy
thumbnail
Congress Presentation
Non-conventional versus conventional pacing in cardiac amyloidosis: impact on clinical, electrical, and functional outcomes
thumbnail
Congress Presentation
Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources